Actionable Mutations and Survival Rates in Non-Small Cell Lung Cancer
World Journal of Oncology
Vol. 16, No. 2, Apr 2025, pages 161-172
By Talal S. Al-Qaisi et al.
Featured in Famous Databases
News & Announcements
Friday, May 9, 2025 - 14:38
Thursday, April 24, 2025 - 06:13
Featured Articles
Oral Pulmonary Arterial Hypertension-Targeted Therapy in Patients With Pulmonary Hypertension due to Interstitial Lung Disease
Journal of Clinical Medicine Research
Vol. 17, No. 3, Mar 2025, pages 153-163
By Kavitha C et al.
Transcranial Direct Current Stimulation in Motor Therapy for Patients With Parkinson’s Disease: A Systematic Review
Journal of Neurology Research
Vol. 15, No. 2, Mar 2025, pages 65-70
By Lucas Brito Meira et al.
Advances in Pathophysiological Mechanisms of Degenerative Aortic Valve Disease
Cardiology Research
Vol. 16, No. 2, Apr 2025 pages 86-101
By Ya Lu Yu et al.
Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
Journal of Endocrinology & Metabolism
Vol. 15, No. 1, Mar 2025, pages 1-14
By Hannah C. Scott et al.
Successful Sentinel Lymph Node Biopsy in Accessory Breast Cancer
Journal of Medical Cases
Vol. 16, No. 3, Mar 2025, pages 107-113
By Young Duck Shin et al.
Histone Lactylation-Driven Ubiquitin-Specific Protease 34 Promotes Cisplatin Resistance in Hepatocellular Carcinoma
Gastroenterology Research
Vol. 18, No. 1, Feb 2025, pages 23-30
By Ming Fan et al.
Prevalence of Viral Infections and Serious Complications in Pediatric Hematopoietic Stem Cell Transplant Patients: A Ten-Year Single-Institution Retrospective Study
Journal of Hematology
Vol. 14, No. 1, Feb 2025, pages 1-13
By Calvin E. Lau et al.
Our Mission
Since 2008, ElmerPress strives to provide the international academic community with maximized quality scientific information throughout a wide spectrum of disciplines. ElmerPress understands how hard, and rigorously scientific information is obtained while relentlessly ensuring it is delivered in the quality and urgency it needs and deserves.
Through Peer-Reviewing, Editing, and Publishing, ElmerPress is committed to making sure every scientific discovery is heard with accuracy, presentability, and appropriate credibility. Our Open Access Journals published by ElmerPress are both Peer-Reviewed, and International, dedicated to the rapid academic exchange. The Publisher currently publishes 14 Open Access Medical Journals, focusing on Clinical Medicine Research in various disciplines.
Browse Our Journals Journal of Clinical Medicine Research Editor-in-Chief: Kei Nakajima , MD,
The single most important criterion for acceptance is the originality of the work. However, a
The quality of your writing is important to accurately convey your research, we are dedicated to
For submission and publishing inquiries, please reach out to our
individual journals
Company Profile
ElmerPress is a medical publishing company based in Toronto, Canada, founded in 2008. With over a decade of experience in the industry, we have established ourselves as a leading provider of high-quality publishing services to clients worldwide. Our team of experienced editors, designers, and project managers work closely with authors, researchers, and publishers to produce medical books, journals, and other publications that are both informative and engaging.
At ElmerPress, we are committed to maintaining the highest standards of quality and professionalism in all our work. We use the latest technology and best practices in the industry to ensure that our clients receive the best possible service and results. Whether you are an author, publisher, or researcher, we are dedicated to helping you achieve your goals and share your work with the world.
Why Choose Us?
Choose ElmerPress for your medical publishing needs to benefit from our decade-long experience in the industry, as well as our commitment to quality and excellence. With a focus on open access and peer-reviewed publications, we offer a range of services to help authors share their research with a global audience.
Seamless Publishing
Our publishing process ensures that you can deliver your research as fast as possible with the quality it deserves.
Our History and Values
Since 2008, ElmerPress has been dedicated to advancing the field of medicine through open access, peer-reviewed publications. We strive to be a reliable partner for authors and readers alike, providing a platform for valuable research to be shared and accessed by a global audience.
Our Committment to Continuous Improvement and Changing Needs
At ElmerPress, we are constantly evolving to meet the changing needs of the medical publishing industry. We invest in cutting-edge technology and stay up-to-date on the latest trends and innovations. Our commitment to continuous improvement allows us to deliver better results and provide an even more seamless experience for our authors and readers
